Ivosidenib (IVO; AG-120) in IDH1-Mutant Newly-Diagnosed Acute Myeloid Leukemia (ND AML): Updated Results from a Phase 1 Study

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • DiNardo, CD; Roboz, GJ; Stein, EM; de Botton, S; Mims, AS; Prince, GT; Altman, JK; Arellano, ML; Donnellan, W; Erba, HP; Mannis, GN; Pollyea, DA; Stein, AS; Uy, GL; Watts, JM; Fathi, AT; Kantarjian, HM; Tallman, MS; Choe, S; Dai, D; Fan, B; Wang, H; Zhang, V; Yen, KE; Kapsalis, SM; Hickman, D; Liu, H; Agresta, SV; Wu, B; Attar, EC; Stone, RM

Published Date

  • September 2019

Published In

Volume / Issue

  • 19 /

Start / End Page

  • S220 - S220

Published By

International Standard Serial Number (ISSN)

  • 2152-2650

Digital Object Identifier (DOI)

  • 10.1016/j.clml.2019.07.094